London, UK, 02 Dec 2021: Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, today announced it has raised a total of $10.5 million USD (£7.8 million GBP) in its seed funding round. The funding will support the continued development of the Company’s Mergo® RNA therapeutics delivery platform.
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Telephone: +44 (0)1223 968 920
Stirling House, Cambridge Innovation Park, Denny End Road, Waterbeach, Cambridge
Post Code: CB25 9QE
Country: United Kingdom
Membership Type: Corporate 6-20